{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:31:56Z","timestamp":1792794716919,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"DOI":"10.1186\/s42358-025-00437-8","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T10:12:05Z","timestamp":1737972725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence, comorbidities, and disease-related complications of rheumatoid arthritis in Colombia: a national cross-sectional study based on administrative claims data"],"prefix":"10.1186","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1649-5290","authenticated-orcid":false,"given":"Kevin","family":"Maldonado-Ca\u00f1\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7466-8244","authenticated-orcid":false,"given":"Giancarlo","family":"Buitrago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-7210","authenticated-orcid":false,"given":"Gerardo","family":"Quintana-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"issue":"1","key":"437_CR1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4(1):18001.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"437_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","volume":"41","author":"K Almutairi","year":"2021","unstructured":"Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021;41(5):863\u201377.","journal-title":"Rheumatol Int"},{"issue":"5","key":"437_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3899\/jrheum.200367","volume":"48","author":"KB Almutairi","year":"2021","unstructured":"Almutairi KB, Nossent JC, Preen DB, Keen HI, Inderjeeth CA. The prevalence of rheumatoid arthritis: a systematic review of Population-based studies. J Rheumatol. 2021;48(5):669\u201376.","journal-title":"J Rheumatol"},{"key":"437_CR4","doi-asserted-by":"publisher","first-page":"K41","DOI":"10.1016\/j.vaccine.2013.03.075","volume":"31","author":"CP Chung","year":"2013","unstructured":"Chung CP, Rohan P, Krishnaswami S, McPheeters ML. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data. Vaccine. 2013;31:K41\u201361.","journal-title":"Vaccine"},{"issue":"4","key":"437_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.rcreu.2018.08.003","volume":"25","author":"J Londo\u00f1o","year":"2018","unstructured":"Londo\u00f1o J, Pel\u00e1ez Ballestas I, Cuervo F, Angarita I, Giraldo R, Rueda JC, et al. Prevalencia de la enfermedad reum\u00e1tica en Colombia, seg\u00fan estrategia COPCORD-Asociaci\u00f3n Colombiana De Reumatolog\u00eda. Estudio De prevalencia de enfermedad reum\u00e1tica en poblaci\u00f3n colombiana mayor de 18 a\u00f1os. Revista Colombiana De Reumatolog\u00eda. 2018;25(4):245\u201356.","journal-title":"Revista Colombiana De Reumatolog\u00eda"},{"issue":"2","key":"437_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.rcreu.2019.01.003","volume":"26","author":"DG Fern\u00e1ndez-\u00c1vila","year":"2019","unstructured":"Fern\u00e1ndez-\u00c1vila DG, Rinc\u00f3n-Ria\u00f1o DN, Bernal-Mac\u00edas S, Guti\u00e9rrez D\u00e1vila JM, Rosselli D. Prevalencia de la artritis reumatoide en Colombia seg\u00fan informaci\u00f3n del Sistema Integral De Informaci\u00f3n De La Protecci\u00f3n Social. Revista Colombiana De Reumatolog\u00eda. 2019;26(2):83\u20137.","journal-title":"Revista Colombiana De Reumatolog\u00eda"},{"issue":"1","key":"437_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.rcreu.2015.12.004","volume":"23","author":"JA D\u00edaz-Rojas","year":"2016","unstructured":"D\u00edaz-Rojas JA, D\u00e1vila-Ram\u00edrez FA, Quintana-L\u00f3pez G, Aristiz\u00e1bal-Guti\u00e9rrez F, Brown P. Prevalencia de artritis reumatoide en Colombia: una aproximaci\u00f3n basada en la carga de la enfermedad durante El a\u00f1o 2005. Revista Colombiana De Reumatolog\u00eda. 2016;23(1):11\u20136.","journal-title":"Revista Colombiana De Reumatolog\u00eda"},{"key":"437_CR8","doi-asserted-by":"crossref","unstructured":"Toloza P\u00e9rez YG. Retos Y soluciones para SISPRO en Colombia. Acta Neurol\u00f3gica Colombiana. 2023;39(2).","DOI":"10.22379\/anc.v39i2.1443"},{"issue":"4","key":"437_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.22379\/24224022426","volume":"38","author":"D Rosselli","year":"2023","unstructured":"Rosselli D, Pantoja-Ruiz C. SISPRO: La base de datos administrativa del sistema de salud colombiano. Acta Neurol\u00f3gica Colombiana. 2023;38(4):187\u201390.","journal-title":"Acta Neurol\u00f3gica Colombiana"},{"key":"437_CR10","unstructured":"Social M de S y P. Bolet\u00edn de aseguramiento en salud. Bolet\u00edn No 01-Primer Trimestre Ministerio de Salud y Protecci\u00f3n Social. 2017."},{"key":"437_CR11","doi-asserted-by":"crossref","unstructured":"Gamboa \u00d3, Buitrago G, Pati\u00f1o AF, Agudelo NR, Espinel LS, Eslava-Schmalbach J et al. Fragmentation of Care and its Association with Survival and costs for patients with breast Cancer in Colombia. JCO Glob Oncol. 2023;(9).","DOI":"10.1200\/GO.22.00393"},{"issue":"8","key":"437_CR12","doi-asserted-by":"publisher","first-page":"e0290734","DOI":"10.1371\/journal.pone.0290734","volume":"18","author":"K Maldonado-Ca\u00f1\u00f3n","year":"2023","unstructured":"Maldonado-Ca\u00f1\u00f3n K, Buitrago G, Molina G, Rinc\u00f3n Tello FM, Maldonado-Escalante J. Teaching hospitals and their influence on survival after valve replacement procedures: a retrospective cohort study using inverse probability of treatment weighting (IPTW). PLoS ONE. 2023;18(8):e0290734.","journal-title":"PLoS ONE"},{"issue":"3","key":"437_CR13","doi-asserted-by":"publisher","first-page":"e0269079","DOI":"10.1371\/journal.pone.0269079","volume":"18","author":"J Amaya-Nieto","year":"2023","unstructured":"Amaya-Nieto J, Torres G, Buitrago G. Prevalence of lung cancer in Colombia and a new diagnostic algorithm using health administrative databases: a real-world evidence study. PLoS ONE. 2023;18(3):e0269079.","journal-title":"PLoS ONE"},{"issue":"11","key":"437_CR14","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3390\/ph15111409","volume":"15","author":"H Oliveros","year":"2022","unstructured":"Oliveros H, Buitrago G. Acute kidney Injury in a cohort of critical illness patients exposed to non-steroidal anti-inflammatory drugs. Pharmaceuticals. 2022;15(11):1409.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"437_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3111\/13696998.2014.969434","volume":"18","author":"JA Rizzo","year":"2015","unstructured":"Rizzo JA, Chen J, Gunnarsson CL, Naim A, Lofland JH. Adjusting for comorbidities in cost of illness studies. J Med Econ. 2015;18(1):12\u201328.","journal-title":"J Med Econ"},{"issue":"3","key":"437_CR16","doi-asserted-by":"publisher","first-page":"e054058","DOI":"10.1136\/bmjopen-2021-054058","volume":"12","author":"H Oliveros","year":"2022","unstructured":"Oliveros H, Buitrago G. Validation and adaptation of the Charlson Comorbidity Index using administrative data from the Colombian health system: retrospective cohort study. BMJ Open. 2022;12(3):e054058.","journal-title":"BMJ Open"},{"issue":"1","key":"437_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/ije\/dyac220","volume":"52","author":"MN Mittinty","year":"2023","unstructured":"Mittinty MN, Lynch J. Reflection on modern methods: risk ratio regression\u2014simple concept yet complex computation. Int J Epidemiol. 2023;52(1):309\u201314.","journal-title":"Int J Epidemiol"},{"key":"437_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.annepidem.2023.08.001","volume":"86","author":"RR Yorlets","year":"2023","unstructured":"Yorlets RR, Lee Y, Gantenberg JR. Calculating risk and prevalence ratios and differences in R: developing intuition with a hands-on tutorial and code. Ann Epidemiol. 2023;86:104\u20139.","journal-title":"Ann Epidemiol"},{"issue":"25","key":"437_CR19","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107.","journal-title":"Stat Med"},{"key":"437_CR20","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. Academic; 2013.","DOI":"10.4324\/9780203771587"},{"issue":"5","key":"437_CR21","first-page":"328","volume":"170","author":"RB Dessau","year":"2008","unstructured":"Dessau RB, Pipper CB. [\u2019\u2019R--project for statistical computing]. Ugeskr Laeger. 2008;170(5):328\u201330.","journal-title":"Ugeskr Laeger"},{"key":"437_CR22","volume-title":"Stata Statistical Software: Release 17. College Station","author":"StataCorp","year":"2021","unstructured":"StataCorp. Stata Statistical Software: Release 17. College Station. TX: StataCorp LLC; 2021."},{"issue":"9","key":"437_CR23","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s10067-023-06628-2","volume":"42","author":"G Shi","year":"2023","unstructured":"Shi G, Liao X, Lin Z, Liu W, Luo X, Zhan H, et al. Estimation of the global prevalence, incidence, years lived with disability of rheumatoid arthritis in 2019 and forecasted incidence in 2040: results from the global burden of Disease Study 2019. Clin Rheumatol. 2023;42(9):2297\u2013309.","journal-title":"Clin Rheumatol"},{"key":"437_CR24","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-\u00c1vila DG, Bernal-Mac\u00edas S, Guti\u00e9rrez JM, Rinc\u00f3n DN, Rosselli D. Prevalence of systemic sclerosis in Colombia: Data from the National Health Registry 2012\u20132016. J Scleroderma Relat Disord [Internet]. 2019;5(2):137\u201342. Available from: https:\/\/doi.org\/10.1177\/2397198319873526","DOI":"10.1177\/2397198319873526"},{"issue":"7","key":"437_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/acr2.11158","volume":"2","author":"DA Marshall","year":"2020","unstructured":"Marshall DA, Pham T, Faris P, Chen G, O\u2019Donnell S, Barber CEH, et al. Determination of rheumatoid arthritis incidence and prevalence in Alberta Using Administrative Health Data. ACR Open Rheumatol. 2020;2(7):424\u20139.","journal-title":"ACR Open Rheumatol"},{"issue":"12","key":"437_CR26","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s10067-017-3796-1","volume":"36","author":"S Jean","year":"2017","unstructured":"Jean S, Hudson M, Gamache P, Bessette L, Fortin PR, Boire G, et al. Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study. Clin Rheumatol. 2017;36(12):2667\u201371.","journal-title":"Clin Rheumatol"},{"issue":"12","key":"437_CR27","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/1756-185X.13974","volume":"23","author":"A Nakajima","year":"2020","unstructured":"Nakajima A, Sakai R, Inoue E, Harigai M. Prevalence of patients with rheumatoid arthritis and age-stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Int J Rheum Dis. 2020;23(12):1676\u201384.","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"437_CR28","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00296-017-3726-1","volume":"37","author":"TM Hunter","year":"2017","unstructured":"Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004\u20132014. Rheumatol Int. 2017;37(9):1551\u20137.","journal-title":"Rheumatol Int"},{"issue":"4","key":"437_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00296-017-3925-9","volume":"38","author":"S Won","year":"2018","unstructured":"Won S, Cho SK, Kim D, Han M, Lee J, Jang EJ, et al. Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization. Rheumatol Int. 2018;38(4):649\u201356.","journal-title":"Rheumatol Int"},{"issue":"10","key":"437_CR30","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","volume":"5","author":"RJ Black","year":"2023","unstructured":"Black RJ, Cross M, Haile LM, Culbreth GT, Steinmetz JD, Hagins H, et al. Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the global burden of Disease Study 2021. Lancet Rheumatol. 2023;5(10):e594\u2013610.","journal-title":"Lancet Rheumatol"},{"key":"437_CR31","unstructured":"Cuenta de Alto Costo. Situaci\u00f3n de la artritis reumatoide en Colombia 2018. Bogot\u00e1; 2019."},{"key":"437_CR32","doi-asserted-by":"crossref","unstructured":"Soriano E, Zucaro NM, Ferreira G, Maciel G, Ringer A, Santos-Moreno P, AB1655\u2005Prevalence of comorbidities in rheumatoid arthritis, psoriatic arthritis and axial spondylarthritis: Results of an International, Real World Panlar\u00b4s register. Ann Rheum Dis [Internet]. 2023;82(Suppl 1):2063. Available from: http:\/\/ard.bmj.com\/content\/82\/Suppl_1\/2063.2.abstract","DOI":"10.1136\/annrheumdis-2023-eular.6366"},{"issue":"1","key":"437_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","volume":"73","author":"M Dougados","year":"2014","unstructured":"Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014;73(1):62\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"437_CR34","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3899\/jrheum.180668","volume":"46","author":"A Luque Ramos","year":"2019","unstructured":"Luque Ramos A, Redeker I, Hoffmann F, Callhoff J, Zink A, Albrecht K. Comorbidities in patients with rheumatoid arthritis and their association with patient-reported outcomes: results of Claims Data Linked to Questionnaire Survey. J Rheumatol. 2019;46(6):564\u201371.","journal-title":"J Rheumatol"},{"issue":"8","key":"437_CR35","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1093\/rheumatology\/keaa856","volume":"60","author":"L Tidblad","year":"2021","unstructured":"Tidblad L, Westerlind H, Delcoigne B, Askling J, Saevarsdottir S. Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control study. Rheumatology. 2021;60(8):3760\u20139.","journal-title":"Rheumatology"},{"issue":"4","key":"437_CR36","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccm.2012.08.003","volume":"33","author":"A Sood","year":"2012","unstructured":"Sood A. Indoor fuel exposure and the lung in both developing and developed countries. Clin Chest Med. 2012;33(4):649\u201365.","journal-title":"Clin Chest Med"},{"issue":"11","key":"437_CR37","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/jpm12111828","volume":"12","author":"V Nociti","year":"2022","unstructured":"Nociti V, Romozzi M. Multiple sclerosis and autoimmune comorbidities. J Pers Med. 2022;12(11):1828.","journal-title":"J Pers Med"},{"issue":"26","key":"437_CR38","doi-asserted-by":"publisher","first-page":"e3999","DOI":"10.1097\/MD.0000000000003999","volume":"95","author":"CC Tseng","year":"2016","unstructured":"Tseng CC, Chang SJ, Tsai WC, Ou TT, Wu CC, Sung WY, et al. Increased incidence of rheumatoid arthritis in multiple sclerosis. Medicine. 2016;95(26):e3999.","journal-title":"Medicine"},{"key":"437_CR39","unstructured":"Ministerio de Salud y Protecci\u00f3n Social. https:\/\/www.minsalud.gov.co\/proteccionsocial\/Paginas\/cifras-aseguramiento-salud.aspx. 2023. Ministerio de Salud y Protecci\u00f3n Social - Cifras de afiliaci\u00f3n en salud."}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00437-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-025-00437-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-025-00437-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T10:12:16Z","timestamp":1737972736000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-025-00437-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1186\/s42358-025-00437-8","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"20 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the IRB of the School of Medicine of the National University of Colombia on October 27, 2021 [N. 020\u2013191]. Individual informed consent was not obtained due to the nature of the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}